Skip NavigationSkip to Content
Return Return to Search Results

Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate Cancer

  1. Author:
    Yerram, Nitin K.
    Long, Lori
    O'Connor, Luke P.
    Wang, Alex Z.
    Ahdoot, Michael
    Lebastchi, Amir H.
    Gurram, Sandeep
    Zeng, Johnathan
    Chalfin, Heather
    Harmon,Stephanie
    Mehralivand, Sherif
    Merino, Maria J.
    Parnes, Howard L.
    Choyke, Peter L.
    Shih, Joanna
    Wood, Bradford J.
    Turkbey, Baris
    Pinto, Peter A.

  2. Author Address

    NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA.NCI, Ctr Intervent Oncol, NIH, Bethesda, MD 20892 USA.NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA.NCI, Clin Res Directorate, Frederick Natl Lab Canc Res, Bethesda, MD 20892 USA.NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA.NCI, Lab Pathol, NIH, Bethesda, MD 20892 USA.NCI, Div Canc Prevent, NIH, Bethesda, MD 20892 USA.
    1. Year: 2021
    2. Date: May
  2. Journal: The Journal of Urology
  3. LIPPINCOTT WILLIAMS & WILKINS,
    1. 205
    2. 5
    3. Pages: 1352-1358
  5. Type of Article: Article
  6. ISSN: 0022-5347
  1. Abstract:

    Purpose: Active surveillance for patients with low and intermediate risk prostate cancers is becoming a more utilized option in recent years. However, the use of magnetic resonance imaging and imaging-targeted biopsy for monitoring grade progression has been poorly studied in this population. We aim to define the utility of magnetic resonance imaging-targeted biopsy and systematic biopsy in an active surveillance population.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1097/JU.0000000000001547
  3. PMID: 33356479
  4. View record in Web of Science®
  5. WOS: 000659189900030

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel